The stark reality of space travel seems to suggest that humanity's presence on the moon is likely to stay tethered to Earth for decades to come.

A pending Supreme Court case and upcoming USCMA talks continue to cloud the outlook for tariffs and trade in 2026.

The problems presented by nuclear energy as an alternative shipping fuel are less about the technology itself, and more about operational feasibility.

In 2026, buyers of insurance won’t necessarily be looking for the cheapest premium, as they exhibit less tolerance for surprise coverage gaps or exclusions.

With all the fancy predictive analytics that firms have adopted in recent years, why are they still slow to respond once they know a disruption is coming down the line?

A letter to the House and Senate Agriculture Committees warns of a "widespread collapse of American agriculture and our rural communities.”

SupplyChainBrain is turning 30! 

Importers might be hoping that the broad tariffs imposed on their products by President Trump will be tempered in 2026. Good luck with that.

GLP-1 drugs are forcing companies to adapt to a sustained shift in consumer behavior and healthcare demand that touches both food and pharma supply chains.

Point-of-sale systems have recently become a particular favorite when it comes to finding vulnerable chinks in the armor.